Twelve multi-functional pyrrolizidinones, indolizidinones and pyrroliazepinones were prepared from formal aza-[3 + 2] and aza-[3 + 3] cycloadditions of five- to seven-membered heterocyclic enaminones as diverse ambident electrophiles. The antitumor activity of these alkaloid-like compounds was investigated through an initial screening performed on human glioblastoma multiform (GBM) cell lines (GL-15, U251), on murine glioma cells line (C6) and on normal glial cells. Of the compounds tested, the new pyrrolo[1,2a]azepinone, [ethyl (3-oxo-1,2-diphenyl-6,7,8,9-tetrahydro-3H-pyrrolo[1,2a]azepin-9a(5H)-yl)acetate] or (Compound-13) exhibited selective cytotoxic effects on GBM-temozolomide resistant cells. Compound-13 exerted dose-dependent cytotoxic activity by promoting arrest of cells in the G0/G1 phase of the cell cycle in the first 24 h. The apoptotic effect observed was in a time-dependent manner. Anti-migratory effect promoted by the treatment with compound-13 was also observed. Moreover, healthy mixed glial cell cultures from rat brain exhibited no cytotoxicity effect upon exposure to compound-13. Thus, the present study paves the way for the use of compound-13 as novel antitumor scaffold candidate for glioma cell therapy.
以五元至七元杂环烯酮作为不同的暧昧亲电体,通过正式的氮杂环合-[3 + 2]和氮杂环合-[3 + 3]环加成反应,制备了 12 种多功能
吡咯烷酮、
吲哚利嗪酮和
吡咯并氮杂卓酮。通过对人类多形性胶质母细胞瘤(GBM)
细胞系(GL-15、U251)、鼠胶质瘤
细胞系(C6)和正常胶质细胞进行初步筛选,研究了这些
生物碱类化合物的抗肿瘤活性。在测试的化合物中,新的
吡咯并[1,2a]氮杂
环庚酮[(3-氧代-1,2
-二苯基-6,7,8,9-四氢-
3H-吡咯并[1,2a]氮杂环庚-9a(5H)-基)
乙酸乙酯]或(化合物-13)对 GBM-
替莫唑胺耐药细胞具有选择性细胞毒性作用。化合物-13 具有剂量依赖性的细胞毒性活性,在细胞周期的前 24 h 促进细胞停滞在 G0/G1 期。观察到的凋亡效应与时间有关。化合物-13 还具有抗迁移作用。此外,来自大鼠大脑的健康混合胶质
细胞培养物在暴露于化合物-13 后没有表现出细胞毒性效应。因此,本研究为将化合物-13 用作胶质瘤细胞治疗的新型抗肿瘤支架候选物铺平了道路。